poliovirus
caus
acut
enter
infect
clinic
manifest
acut
flaccid
paralysi
afp
possibl
death
world
health
assembl
wha
formal
endors
effort
erad
polio
global
polio
erad
initi
gpei
case
paralyt
polio
declin
enorm
case
case
paralyt
polio
caus
one
wild
polioviru
wpv
uniqu
epidemiolog
immun
respons
vaccin
requir
current
remain
case
wpv
infect
global
due
last
natur
occur
case
infect
octob
novemb
global
commiss
certif
erad
poliomyel
certifi
erad
type
polioviru
septemb
make
type
polioviru
first
human
pathogen
erad
sinc
agent
smallpox
enorm
progress
toward
polio
erad
includ
absenc
type
year
restrict
highrisk
state
countri
bring
erad
effort
final
chapter
otherwis
known
polio
endgam
reason
success
polio
erad
effort
date
includ
advanc
polio
research
innov
vaccinolog
laboratori
detect
genotyp
epidemiolog
polici
intens
innov
effort
deliv
vaccin
target
popul
worldwid
supplement
journal
infecti
diseas
focus
operation
effort
ensur
success
polio
endgam
includ
essenti
chang
global
polio
vaccin
polici
name
begin
phase
withdraw
oral
polioviru
vaccin
opv
combin
introduct
inactiv
polioviru
vaccin
ipv
launch
activ
document
transit
polio
resourc
lesson
learn
prioriti
global
health
initi
figur
histor
vaccinologist
develop
endors
vaccin
trival
opv
ipv
control
elimin
anticip
erad
polio
vaccin
contain
poliovirus
either
live
attenu
virus
administ
oral
opv
inactiv
virus
administ
thru
parenter
inject
ipv
expert
worldwid
intens
debat
role
vaccin
erad
effort
year
understand
vaccin
also
evolv
year
although
vaccin
use
year
global
consensu
joint
role
vaccin
polio
erad
effort
recent
taken
shape
year
polio
endgam
strategi
also
evolv
outset
envis
strategi
simpler
erad
world
wpv
use
opv
follow
discontinu
opv
howev
basi
improv
understand
poliovirus
vaccin
current
erad
effort
necessit
nuanc
undoubtedli
complic
approach
endgam
use
opv
accept
doubleedg
sword
opv
primari
reason
enorm
success
polio
control
global
also
rare
occas
caus
either
sporad
vaccineassoci
paralyt
polio
vapp
vaccin
recipi
close
contact
outbreak
vaccinederiv
poliovirus
vdpv
latter
instanc
gut
replic
transmiss
subsequ
chain
contact
opv
evolv
multipl
genet
nucleotid
chang
frequent
recombin
nonpolioviru
enteroviru
c
speci
rare
case
vaccin
viru
may
regain
neurovirul
acquir
transmiss
compar
wpv
thu
caus
outbreak
paralyt
polio
relat
vdpv
clinic
indistinguish
paralysi
due
wpv
dozen
similar
outbreak
report
worldwid
sinc
first
welldocu
confirm
outbreak
vdpv
hispaniola
outbreak
occur
area
low
opv
coverag
creat
larg
pool
poliosuscept
person
allow
vdpv
circul
cvdpv
howev
uncertain
term
case
paralysi
due
cvdpv
rare
far
outweigh
immens
benefit
opv
wpv
erad
world
must
ceas
use
opv
global
erad
polio
ultim
must
includ
erad
paralyt
polio
due
form
live
poliovirus
recurr
detect
cvdpv
outbreak
prompt
expert
rethink
endgam
strategi
erad
type
viru
account
approxim
report
cvdpv
approxim
vaccineassoci
paralyt
polio
case
furthermor
type
vaccin
viru
immunogen
vaccin
viru
strain
opv
interfer
replic
type
intestin
tract
henc
take
immun
respons
thu
opv
withdraw
would
phase
begin
cessat
type
compon
opv
switch
use
trival
opv
topv
contain
polioviru
type
use
bival
opv
bopv
contain
polioviru
type
use
bopv
would
continu
certif
erad
cessat
use
inher
risk
reemerg
type
viru
figur
model
shown
risk
reemerg
although
low
would
increas
first
year
cessat
owe
declin
type
immun
context
silent
undetect
transmiss
longerterm
risk
wpv
may
also
exist
breach
laboratori
contain
intent
releas
viru
occur
gpei
approach
mitig
risk
seri
key
readi
step
prior
switch
includ
control
outbreak
ensur
high
immun
type
polioviru
prepar
postswitch
type
surveil
outbreak
respons
protocol
expand
environment
surveil
stockpil
monoval
deal
potenti
outbreak
contain
essenti
facil
perhap
relev
world
countri
worldwid
would
introduc
ipv
routin
immun
ri
system
help
reduc
risk
reintroduc
type
polioviru
provid
level
popul
immun
type
facilit
interrupt
transmiss
outbreak
occur
fundament
countri
would
need
convinc
rational
clear
polici
mandat
suffici
resourc
use
ipv
costlier
logist
difficult
administ
opv
caus
paralyt
polio
implement
part
polio
endgam
make
complex
endeavor
polio
erad
effort
resourc
intens
go
forev
transmiss
wild
virus
interrupt
erad
certifi
narrow
window
time
exist
within
endgam
must
accomplish
anticip
erad
type
polioviru
wha
may
endors
gpei
polio
erad
endgam
strateg
plan
plan
outlin
object
figur
comprehens
address
erad
polio
endgam
strategi
contain
poliovirus
essenti
facil
polio
legaci
ie
transit
process
object
deal
endgam
compon
call
phase
withdraw
opv
begin
withdraw
type
compon
object
call
initi
action
maintain
mainstream
essenti
polio
function
eg
surveil
immun
contain
postpolio
erad
world
transit
invest
polio
erad
benefit
prioriti
public
health
initi
year
come
countri
use
opv
would
requir
access
least
dose
ipv
effici
use
polio
resourc
would
need
occur
prioriti
countri
gpei
presenc
strong
polio
infrastructur
present
strengthen
ri
servic
facilit
withdraw
week
april
opvus
countri
territori
would
withdraw
global
synchron
switch
use
topv
bopv
implement
variou
aspect
object
endgam
plan
cover
articl
supplement
section
ipv
switch
strengthen
immun
servic
transit
plan
supplement
comprehens
represent
work
global
arena
relat
polio
endgam
rather
provid
glimps
key
activ
within
key
domain
endgam
across
global
region
nation
level
implement
endgam
gpei
launch
immun
system
manag
group
consist
member
core
partner
agenc
gavi
vaccin
allianc
agenciesth
world
health
organ
unit
nation
children
fund
unicef
center
diseas
control
prevent
cdc
rotari
bill
melinda
gate
foundationar
core
partner
gpei
also
happen
influenti
heavili
involv
agenc
global
immun
arena
implement
endgam
result
truli
success
collabor
among
larg
agenc
complex
work
structur
bureaucraci
serv
model
futur
collabor
associ
similarli
challeng
global
health
initi
first
section
supplement
deal
seri
articl
describ
lesson
learn
global
partner
regard
structur
global
coordin
mechan
financi
support
mechan
regulatori
challeng
commun
advocaci
effort
suppli
consider
global
coordin
implement
polio
endgam
coordin
support
global
level
import
implement
ultim
occur
nation
level
support
region
offic
unicef
local
implement
partner
colleagu
region
offic
discuss
challeng
creativ
solut
implement
region
nation
level
introduc
ipv
banguz
et
al
describ
countri
level
effort
engag
nation
immun
advisori
group
facilit
countryspecif
polici
consider
indonesia
uganda
scotney
et
al
cover
broad
spectrum
challeng
lesson
ipv
introduct
cameroon
nigeria
kenya
evalu
bangladesh
illustr
implement
challeng
relat
ensur
cold
chain
capac
minim
wastag
accept
vaccin
improv
coverag
introduct
ipv
ri
program
alreadi
use
pentaval
vaccin
cover
diphtheria
tetanu
pertussi
haemophilu
influenza
type
b
hepat
b
pneumococc
vaccin
result
need
administ
inject
singl
visit
concern
emerg
staff
nation
immun
program
provid
region
world
regard
safeti
accept
multipl
inject
dolan
et
al
subaiya
et
al
provid
evid
global
landscap
analysi
recent
evalu
albania
support
notion
caretak
provid
appreci
health
benefit
vaccin
deem
outweigh
concern
pain
inconveni
associ
multipl
inject
issu
evalu
strateg
advisori
group
expert
sage
immun
conclud
deliveri
pentaval
vaccin
pneumococc
vaccin
ipv
singl
visit
safe
effect
well
accept
vaccin
caregiv
mani
countri
midapril
midmay
opvus
countri
territori
discontinu
use
type
opv
switch
topv
bopv
nation
immun
program
switch
includ
complex
milieu
activ
includ
cessat
topv
product
shipment
manufactur
nation
inventori
topv
detail
forecast
topv
need
bopv
licens
scale
bopv
product
procur
develop
nation
oper
switch
plan
secur
fund
establish
oversight
implement
committe
team
train
logistician
health
worker
foster
advocaci
commun
establish
monitor
valid
structur
implement
wast
manag
strategi
figur
activ
occur
across
global
region
level
involv
complex
interplay
variou
agenc
nation
govern
manufactur
importantli
switch
synchron
countri
territori
vari
level
infrastructur
capac
legisl
manufactur
contract
unpreced
achiev
uncertain
term
relat
strong
collabor
partnership
nation
govern
unit
nation
agenc
support
partner
agenc
donor
regulatori
agenc
manufactur
sever
articl
illumin
factor
lead
success
switch
includ
advanc
plan
establish
polici
design
protect
popul
ensur
suffici
programmat
flexibl
safe
implement
switch
identif
dissemin
human
financi
resourc
time
dissemin
standard
easili
digest
protocol
suppli
consider
lynchpin
synchron
withdraw
ensur
suffici
topv
avail
switch
without
abund
excess
unus
stock
would
requir
destruct
switch
complic
matter
countri
vari
electron
paperbas
stock
manag
system
contract
supplier
stock
capac
train
monitor
legisl
resourc
vaccin
dispos
rubin
et
al
describ
global
vaccin
suppli
market
suppli
consider
plan
cessat
topv
use
ramirez
et
al
provid
intric
detail
overal
switch
plan
implement
global
perspect
sever
articl
colleagu
unicef
region
offic
provid
region
nation
experi
switch
although
plan
strategi
coordin
across
level
global
nation
local
among
relev
partner
stakehold
crucial
monitor
outcom
provid
greater
confid
regard
valid
withdraw
billion
dose
topv
use
year
across
sever
hundr
thousand
health
facil
countri
territori
sheer
magnitud
task
monitor
valid
withdraw
unwieldi
howev
farrel
et
al
describ
practic
sound
monitor
valid
strategi
result
vaccin
store
nation
region
district
health
facil
level
respect
monitor
global
short
span
week
ensur
vast
major
topv
withdrawn
use
global
synchron
switch
window
withdrawn
topv
could
still
make
way
back
cold
chain
possibl
result
ongo
use
gener
vdpv
destroy
withdrawn
topv
crucial
aspect
switch
wanyoik
et
al
provid
overview
challeng
novel
practic
solut
destruct
dispos
unus
vaccin
simultan
across
countri
particularli
resourcepoor
set
destruct
unus
vaccin
larg
unchart
territori
prior
switch
document
experi
provid
relev
learn
withdraw
opv
erad
erad
succeed
immun
system
must
capabl
adopt
deliv
vaccin
accord
nation
immun
schedul
ri
system
increas
polio
immun
vaccin
provid
ri
system
one
import
pillar
polio
erad
moreov
robust
ri
system
also
provid
foundat
control
childhood
vaccin
prevent
diseas
thu
effort
erad
polio
occur
vacuum
polio
resourcesfin
personnel
equip
experiencecontribut
ri
servic
particularli
countri
larg
gpei
presenc
endgam
activ
offer
uniqu
opportun
improv
collabor
global
immun
partner
work
polio
ri
system
make
effici
use
gpei
resourc
strengthen
ri
activ
particularli
relev
countri
larg
gpei
presenc
highrisk
target
popul
weak
immun
system
sever
articl
supplement
take
stock
gpei
resourc
support
ri
activ
contribut
strengthen
ri
servic
specif
aim
identifi
servic
may
risk
polio
resourc
diminish
erad
deutsch
et
al
ongwa
et
al
describ
use
polio
resourc
social
mobil
network
experi
may
also
valuabl
broader
health
program
ri
activ
van
den
ent
et
al
identifi
sever
key
factor
behind
success
polio
erad
program
highrisk
prioriti
countri
includ
govern
leadership
evidencebas
program
commun
partnership
strong
account
system
provid
specif
exampl
factor
experi
posit
leverag
broader
immun
activ
provid
motiv
pursu
synergi
polio
ri
program
effort
horizont
vertic
immun
program
inde
coexist
synergist
strive
meet
share
goal
improv
child
health
global
illustr
van
den
ent
et
al
polio
infrastructur
workforc
financi
resourc
substanti
contribut
immun
servic
beyond
polio
moreov
gpei
amass
tremend
use
lesson
programmat
experi
past
decad
one
largest
mobil
public
health
commun
histori
toward
one
diseas
secur
gain
polio
erad
futur
gener
requir
essenti
function
polio
program
need
continu
maintain
immun
polio
erad
certifi
sustain
acut
flaccid
paralysi
environ
surveil
maintain
outbreak
respons
capac
rutter
et
al
provid
overview
postpolio
erad
transit
plan
describ
consider
risk
associ
loss
current
polio
asset
infrastructur
well
substanti
opportun
build
invest
benefit
nation
global
health
prioriti
transit
plan
previous
refer
legaci
core
compon
endgam
plan
continu
forward
progress
global
nation
immun
program
face
anticip
ramp
polio
resourc
infrastructur
current
contribut
substanti
toward
support
overal
ongo
immun
system
challeng
effect
respons
transit
polio
resourc
capac
experi
toward
global
public
health
prioriti
midterm
review
global
vaccin
action
plan
emphas
countri
mitig
risk
sustain
effect
immun
program
polio
fund
decreas
p
sever
articl
highlight
capac
asset
gpei
support
immun
global
health
prioriti
support
must
continu
risk
neg
consequ
immun
health
system
william
et
al
describ
polio
surveil
system
serv
platform
vaccineprevent
diseas
surveil
associ
support
experi
lesson
learn
play
key
role
develop
global
region
network
vaccineprevent
diseas
gpei
contribut
substanti
effort
elimin
measl
rubella
global
nation
gpeiiniti
social
mobil
network
poliofund
global
posit
system
map
activ
support
microplan
use
extend
health
prioriti
stop
transmiss
polio
program
expand
workforc
develop
activ
far
beyond
polio
includ
ri
activ
vaccineprevent
diseas
surveil
measl
rubella
elimin
commun
social
mobil
immun
data
qualiti
exampl
reach
gpei
stake
potenti
opportun
polio
transit
plan
meaning
address
although
world
made
substanti
progress
polio
endgam
past
year
articl
supplement
also
highlight
specif
challeng
gap
relev
futur
immun
work
includ
area
capac
build
nation
immun
advisori
group
nation
regulatori
mechan
selfprocur
vaccin
financ
support
immun
activ
middleincom
countri
expand
maintain
function
cold
chain
stock
manag
transport
wast
manag
issu
relat
accept
multipl
inject
tie
content
socal
vertic
program
polio
erad
introduct
new
vaccin
may
reli
strong
ri
system
success
may
necessarili
strengthen
system
strengthen
ri
system
deserv
invest
attent
ultim
countri
commend
introduc
commit
introduc
least
dose
ipv
prior
switch
howev
manufactur
commit
meet
demand
plan
acceler
ipv
introduct
encount
repeat
unforeseen
setback
provid
contractu
agre
upon
ipv
suppli
relat
rapid
scale
complex
product
process
thu
mani
countri
current
face
shortag
stockout
ipv
howev
global
partner
manufactur
countri
work
close
find
innov
accept
solut
temporari
setback
includ
apport
limit
stock
highestrisk
popul
use
dosespar
fraction
dose
ie
one
fifth
full
vaccin
dose
fipv
ipv
will
countri
hiro
et
al
provid
review
immunogen
oper
data
support
intraderm
use
fipv
use
fipv
ri
activ
potenti
supplementari
immun
activ
outbreak
could
eas
suppli
situat
would
requir
logist
consider
countri
high
wastag
vial
potenti
regulatori
concern
offlabel
use
fipv
challeng
procur
intraderm
syring
devic
train
health
worker
administr
vaccin
intraderm
india
sri
lanka
success
adopt
dose
fipv
ri
system
nationwid
other
may
follow
lead
although
countri
express
concern
logist
challeng
compet
prioriti
assur
suppli
even
fipv
global
partner
year
also
invest
longterm
strategi
engag
addit
supplier
immun
strategi
would
provid
protect
polio
erad
includ
sabin
ipv
adjuv
ipv
combin
ipv
product
safer
version
opv
microneedl
patch
switch
topv
bopv
larg
deem
success
billion
dose
use
per
year
global
goal
global
synchron
switch
mitig
risk
reduc
risk
much
possibl
balanc
risk
prioriti
avail
resourc
sinc
switch
environment
stool
surveil
identifi
sporad
detect
sabinlik
type
poliovirus
indic
ongo
use
topv
switch
detect
hyderabad
ahmedabad
india
extens
investig
month
switch
identifi
limit
use
topv
privat
clinic
approxim
vial
approxim
privat
clinic
retail
sampl
thu
countri
unlik
withdrawn
everi
singl
vial
particularli
privat
sector
challeng
monitor
govern
isol
scenario
use
limit
amount
topv
surpris
given
magnitud
topv
use
year
prior
switch
howev
first
year
switch
outbreak
attribut
ongo
use
topv
support
content
vast
major
topv
withdrawn
global
hampton
et
al
discuss
implic
switch
experi
opv
withdraw
polio
erad
note
higher
stake
polio
erad
may
justifi
aggress
approach
opv
withdraw
involv
advanc
plan
fund
monitor
attent
withdraw
privat
sector
outcom
introduc
ipv
nearli
countri
acceler
manner
compress
time
frame
year
success
withdraw
global
aprilmay
support
view
immun
system
manag
group
stakehold
nation
govern
immun
program
succeed
achiev
first
phase
polio
endgam
moreov
without
serious
affect
daytoday
oper
includ
introduct
new
vaccin
respons
outbreak
exampl
period
countri
introduc
rotaviru
vaccin
introduc
pneumococc
vaccin
mani
countri
also
dealt
seriou
civil
region
conflict
outbreak
due
middl
east
respiratori
syndrom
coronaviru
ebola
viru
zika
viru
collect
experi
outlin
articl
supplement
provid
optim
futur
global
health
initi
measl
rubella
erad
endgam
experi
key
factor
success
includ
global
mandat
countri
author
eg
wha
clariti
polici
eg
strateg
advisori
group
immun
guidanc
financi
resourc
eg
donor
support
commit
highest
level
core
partner
agenc
moreov
articl
also
indic
align
global
factor
polio
endgam
foster
facilit
true
collabor
spirit
among
highli
motiv
individu
member
partner
agenc
commit
goal
polio
erad
articl
author
individu
supplement
serv
optimist
exampl
achiev
global
health
effect
collabor
determin
also
provid
blueprint
futur
work
gpei
close
polio
erad
withdraw
opv
global
near
futur
thu
secur
gain
erad
perman
work
summar
supplement
demonstr
proper
support
countri
immun
program
strong
capac
absorb
adapt
new
global
health
initi
immun
ultim
design
reduc
burden
infecti
diseas
provid
healthier
live
children
worldwid
erad
diseas
human
popul
easi
accomplish
human
histori
howev
perman
erad
justifi
effort
put
forth
provid
ultim
form
equiti
health
live
today
futur
gener
come
